Literature DB >> 10584732

Treatment of traumatic bleeding with recombinant factor VIIa.

G Kenet, R Walden, A Eldad, U Martinowitz.   

Abstract

Surgical intervention failed to stop life-threatening bleeding caused by injury complicated by severe coagulopathy. Administration of recombinant factor VIIa immediately corrected the coagulopathy and bleeding stopped.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10584732     DOI： 10.1016/S0140-6736(99)05155-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  43 in total

Review 1.  The use of recombinant activated coagulation factor VII for spine surgery.

Authors:  Richard B Weiskopf
Journal:  Eur Spine J       Date:  2004-05-25       Impact factor: 3.134

Review 2.  Recombinant factor VIIa: a review on its clinical use.

Authors:  Massimo Franchini
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

3.  Successful outcome of DIC and life-threatening bleeding in a toddler with neuroblastoma treated with recombinant activated factor VII.

Authors:  Emmanouil S Hatzipantelis; Nikolaos Gombakis; Vasiliki Sidi; Evgenia Papakonstantinou; Dimitrios E Koliouskas
Journal:  Intern Emerg Med       Date:  2008-02-09       Impact factor: 3.397

4.  Off-label use of recombinant factor VIIa: why we need better drug monitoring.

Authors:  Paul C Hébert; Dean Fergusson; Matthew B Stanbrook
Journal:  CMAJ       Date:  2011-01-11       Impact factor: 8.262

5.  Recombinant factor VIIa: use in fatal post partum hemorrhage - Indian experience case series and review of literature.

Authors:  Shailesh R Singi; Evita Fernandez; Sunil T Pandya; H R Badrinath
Journal:  Indian J Hematol Blood Transfus       Date:  2009-04-06       Impact factor: 0.900

6.  Recombinant Factor VIIA.

Authors:  P Kinra; H Kumar
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  A Fibrin Cross-linking Polymer Enhances Clot Formation Similar to Factor Concentrates and Tranexamic Acid in an in vitro Model of Coagulopathy.

Authors:  Leslie W Chan; Nathan J White; Suzie H Pun
Journal:  ACS Biomater Sci Eng       Date:  2016-01-28

8.  Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs.

Authors:  Jun Zhang; Robert F Groff; Xiao-Han Chen; Kevin D Browne; Jason Huang; Eric D Schwartz; David F Meaney; Victoria E Johnson; Sherman C Stein; Rasmus Rojkjaer; Douglas H Smith
Journal:  Exp Neurol       Date:  2008-01-05       Impact factor: 5.330

9.  The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII.

Authors:  Amanda Zatta; Zoe Mcquilten; Rangi Kandane-Rathnayake; James Isbister; Scott Dunkley; John Mcneil; Peter Cameron; Louise Phillips
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

10.  Successful use of recombinant activated factor VII for postoperative associated haemorrhage: a case report.

Authors:  Konstantinos Vlachos; Fotis Archontovasilis; Artemisia Papadima; Dimitrios Maragiannis; Stavros Aloizos; Emmanuel Lagoudianakis; Ioannis G Dalianoudis; Nikolaos Koronakis; John Chrysikos; Spyros Zaravinos; Andreas Manouras
Journal:  Cases J       Date:  2008-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.